Treatment of Bilateral Iliac Aneurysms with Gore Iliac Branch Endoprostheses: Case Report and Review of the Literature

Sruthi Muluk and Naval Udgiri

Harvard College, USA
Department of Vascular Surgery, St. Vincent Regional Health System, USA

^*Correspondance to: Sruthi Muluk 

 PDF  Full Text DOI: 10.25107/2474-1647.1179

Abstract

Introduction: Bilateral common iliac aneurysms that extend to the distal portion cannot be readily treated with standard endografts. A common strategy for unilateral iliac aneurysms is to embolize and cover the internal iliac on the side of the aneurysm, but this strategy is associated with significant side effects. The coil/cover approach is particularly undesirable for bilateral iliac aneurysms. The recent introduction of the Gore Iliac Branch Endoprosthesis (IBE) facilitates preservation of flow to the internal iliac. In this paper, we describe the first reported case of using two IBE devices to treat a patient with bilateral iliac aneurysms.Case
Presentation: A 75-year old male presented with asymptomatic bilateral common iliac aneurysms. He was treated with bilateral Gore Excluder® Iliac Branch Endoprostheses. The patient tolerated the procedure well and follow-up imaging showed no endoleak and patency of all relevant arteries.Discussion: Bilateral common iliac aneurysms which extend to the distal iliac pose a problem because the traditional coil/cover strategy can lead to symptoms such as sexual dysfunction and buttock claudication. There are several other methods of treating this subset of aneurysms, including iliac branch devices (IBDs). The early literature on the use of IBDs is promising. This case presentation demonstrates that bilateral IBDs can be successfully used in patients with suitable anatomy.

Keywords

Bilateral iliac aneurysms; Endoprostheses; Chronic warfarin therapy; Iliac aneurysms (IA)

Cite the article

Muluk S, Udgiri N. Treatment of Bilateral Iliac Aneurysms with Gore Iliac Branch Endoprostheses: Case Report and Review of the Literature. Clin Surg. 2016; 1: 1179.